ArticleCase reports in neurological medicine2025
Pituitary Macroadenoma and Adamantinomatous Craniopharyngioma: A Rare Case Report of Sellar Collision Tumors.
Article in Case reports in neurological medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Case Report: Sellar collision tumor consisting of pituitary adenoma and craniopharyngioma, with literature review.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We present a rare case of a collision tumor involving a pituitary macroadenoma and adamantinomatous craniopharyngioma in a 49-year-old woman. The patient presented with a 2-year history of amenorrhea and elevated prolactin. Brain MRI revealed two sellar masses. Initially managed with observation due to the absence of neurological deficits, surgical resection was later performed after clinical and radiographic progression. Pathology confirmed both tumor types: pituitary macroadenoma and adamantinomatous craniopharyngioma. Postoperative MRI showed residual disease at the superior margin. The patient subsequently received fractionated stereotactic radiation for residual disease and tolerated well.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.